COLL vs CPIX

Collegium Pharmaceutical, Inc. vs Cumberland Pharmaceuticals Inc. — Valuation Comparison 2026

COLL

Drug Manufacturers - Specialty & Generic
Collegium Pharmaceutical, Inc.
Quality
9.2
out of 10
Value Trap
23
SAFE
Price
$33.37
Last close
Models
12/13
Active
VS

CPIX

Drug Manufacturers - Specialty & Generic
Cumberland Pharmaceuticals Inc.
Quality
6.4
out of 10
Value Trap
32
LOW
Price
$5.98
Last close
Models
12/13
Active

Model-by-Model Comparison

ModelType COLL Fair ValueCOLL Upside CPIX Fair ValueCPIX Upside
Bayesian DCF Intrinsic $138.55 +315.2% $3.87 -35.3%
Earnings Power Value Intrinsic $30.34 -9.1% $1.09 -81.8%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for COLL vs CPIX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

COLL vs CPIX — Which Stock Is More Undervalued?

COLL scores higher with a 9.2/10 quality rating vs CPIX's 6.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Collegium Pharmaceutical, Inc. (COLL) and Cumberland Pharmaceuticals Inc. (CPIX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

COLL currently trades at $33.37 with a QOC of 9.2/10, while CPIX trades at $5.98 with a QOC of 6.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).